Consumer Goods & Retail Global On demand · 24-48h

Global Pet (Cat and Dog) Genetic Test Kit Market Strategic Research Report

Name: Global Pet (Cat and Dog) Genetic Test Kit Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Pet (Cat and Dog) Genetic Test Kit Market Strategic R…

$3,500 USD

Strategic Research Report

Global Pet (Cat and Dog) Genetic Test Kit Market

$2462025

11%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Hair Test, Saliva Test

By Application: Breed Identification, Health Insights, Tailored Care, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Embark Veterinary, Mars Petcare (Wisdom Panel), Orivet Genetic Pet Care, DNA My Dog (Canadian Dog Group), Ancestry, TellmeGen (Koko Genetics), Meidike Gene, Basepaws, EasyDNA, VetGen, Royal Canin, Thermo Fisher Scientific

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 111 pages

Market size 2025

$246

Million USD

Forecast CAGR

11%

2025-2032

Forecast 2032

$510.7

Projected

Régions

Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Pet (Cat and Dog) Genetic Test Kit market size is predicted to grow from US$ 246 million in 2025 to US$ 504 million in 2032; it is expected to grow at a CAGR of 11.0% from 2026 to 2032.

A Pet Genetic Test Kit, also known as a Cat and Dog Genetic Test Kit, is a product designed to provide insights into the genetic makeup and heritage of your pet. These kits are similar to the popular human DNA test kits that have become widely available in recent years. The purpose of a Pet Genetic Test Kit is to analyze your cat or dog's DNA, revealing information about their breed ancestry, health-related genetic markers, and potential predispositions to certain diseases or traits.

In 2024, the global production of pet DNA testing kits reached 2.8 million units, with an average selling price of US$90 per unit.

The Pet Genetic Test Kit market has experienced rapid growth in recent years, with dog DNA testing leading the market, followed by cat DNA testing. Key drivers include the increasing humanization of pets, rising demand for genetic disease screening, and the standardization of purebred pet breeding. North America accounts for over 50% of the market, with emerging markets such as China experiencing significant growth. International brands such as Embark and Wisdom Panel have dominated the high-end market with their technological advantages, while Chinese manufacturers are rapidly expanding through cost-effective strategies. In the future, with the decreasing cost of whole-genome sequencing technology and the rise of value-added services such as pet insurance, the market is expected to maintain annual growth rates exceeding 10%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pet (Cat and Dog) Genetic Test Kit market?

What factors are driving Pet (Cat and Dog) Genetic Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pet (Cat and Dog) Genetic Test Kit market opportunities vary by end market size?

How does Pet (Cat and Dog) Genetic Test Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Pet (Cat and Dog) Genetic Test Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Hair Test
Saliva Test

Segment by Application

Breed Identification
Health Insights
Tailored Care
Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pet (Cat and Dog) Genetic Test Kit market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Breed Identification, Health Insights, Tailored Care evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pet (Cat and Dog) Genetic Test Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 11%

Regional growth momentum

Market share by segment

Key metrics

Base value

$246

2025

Forecast

$510.7

2032

CAGR

11%

2025–2032

Régions

global

Key companies

Embark VeterinaryMars Petcare (Wisdom Panel)Orivet Genetic Pet CareDNA My Dog (Canadian Dog Group)AncestryTellmeGen (Koko Genetics)Meidike GeneBasepaws

Segments covered in this report

By Type

Hair TestSaliva Test

By Application

Breed IdentificationHealth InsightsTailored CareOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Hair Test
3.1.3 Saliva Test
3.1.4 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Breed Identification
4.1.3 Health Insights
4.1.4 Tailored Care
4.1.5 Others
4.1.6 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Embark Veterinary
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Mars Petcare (Wisdom Panel)
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Orivet Genetic Pet Care
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 DNA My Dog (Canadian Dog Group)
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Ancestry
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 TellmeGen (Koko Genetics)
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Meidike Gene
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Basepaws
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 EasyDNA
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 VetGen
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Royal Canin
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Thermo Fisher Scientific
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Pet (Cat and Dog) Genetic Test Kit market size?

The global Pet (Cat and Dog) Genetic Test Kit market is estimated at US$ 246 million in 2025 (base year) and is projected to reach US$ 504 million by 2032.

What growth rate is expected for the Pet (Cat and Dog) Genetic Test Kit market through 2032?

The market is expected to grow at a CAGR of 11.0% from 2026 to 2032, expanding from US$ 246 million in 2025 to US$ 504 million in 2032, roughly 2.0 times its base-year value.

How is Pet (Cat and Dog) Genetic Test Kit defined?

What are the main segments of the Pet (Cat and Dog) Genetic Test Kit market by type?

By type, the market is segmented into Hair Test and Saliva Test.

Which applications drive demand in the Pet (Cat and Dog) Genetic Test Kit market?

Key applications covered include Breed Identification, Health Insights, Tailored Care and Others.

Who are the key players in the Pet (Cat and Dog) Genetic Test Kit market?

Key players profiled include Embark Veterinary, Mars Petcare (Wisdom Panel), Orivet Genetic Pet Care, DNA My Dog (Canadian Dog Group), Ancestry, TellmeGen (Koko Genetics), Meidike Gene and Basepaws, among 12 companies covered in total.

Which regions and countries are covered for Pet (Cat and Dog) Genetic Test Kit?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What is driving growth in the Pet (Cat and Dog) Genetic Test Kit market?

What factors are driving Pet (Cat and Dog) Genetic Test Kit market growth, globally and by region?

Who should buy the Pet (Cat and Dog) Genetic Test Kit market report?

The report is intended for manufacturers and solution providers, distributors and end users in Breed Identification, Health Insights and Tailored Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pet (Cat and Dog) Genetic Test Kit market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.